Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ICAD Inc ICAD

Healthcare Medical Devices
iCAD, Inc. provides artificial intelligence-powered cancer detection. Its ProFound Breast Health Suite enables medical providers and professionals to accurately and reliably identify where cancer may be hiding. Its Cancer Detection segment solutions include advanced artificial intelligence and image analysis workflow solutions that enable healthcare professionals to better serve patients by... see more

Recent & Breaking News (NDAQ:ICAD)

iCAD Releases Enhanced ProFound Detection Workstation Features to Streamline Mammogram Interpretation for Radiologists

GlobeNewswire March 19, 2024

iCAD Announces Fiscal Fourth Quarter and Full-Year 2023 Financial Results

GlobeNewswire March 12, 2024

iCAD Highlights Promising Clinical Data Demonstrating Ability to Reduce Breast Interval Cancer Rates and Decrease Recall Rates at ECR 2024; Showcases Additional Platform Offerings

GlobeNewswire February 28, 2024

iCAD expands Board of Directors with the appointment of Dr. Hedvig Hricak, MD, PhD, (Dr.h.cᵐ)

GlobeNewswire February 27, 2024

iCAD to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024

GlobeNewswire February 27, 2024

iCAD to Participate in the BTIG at Snowbird: 11th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

GlobeNewswire February 6, 2024

iCAD Expands Board of Directors with Appointment of Michael J. Doyle, FACHE as New Board Member

GlobeNewswire January 30, 2024

iCAD Expands Executive Sales Leadership Team as Business Grows

GlobeNewswire December 18, 2023

iCAD's AI-powered solutions to Help Accelerate Breast Cancer Detection in New Collaboration with GE Healthcare

GlobeNewswire November 28, 2023

iCAD's ProFound AI Can Predict 1-2 Year Risk for Breast Cancer and Reveal Insights for Heart Disease

GlobeNewswire November 27, 2023

iCAD and CancerIQ Announce Partnership to Integrate AI-Enabled Technology With Best-in-Class Risk Assessment and Care Management Platform Offering A Comprehensive Breast Health Care Solution  

GlobeNewswire November 20, 2023

iCAD to Participate in the 14th Annual Craig-Hallum Alpha Select Conference

GlobeNewswire November 14, 2023

iCAD Reports Financial Results for Third Quarter Ended September 30, 2023

GlobeNewswire November 13, 2023

iCAD to Report Third Quarter 2023 Financial Results on November 13, 2023

GlobeNewswire October 30, 2023

iCAD, Inc. Announces Sale of Xoft, its Brachytherapy Business Line, to Elekta

GlobeNewswire October 23, 2023

Health Canada Grants Device License for iCAD's ProFound Risk 2.0, Revolutionizing Breast Cancer Risk Via a 1-2 Year Assessment

GlobeNewswire August 16, 2023

iCAD Reports Financial Results for Second Quarter Ended June 30, 2023 

GlobeNewswire August 14, 2023

iCAD and Google Health Expand Integration of Google's AI Technology with iCAD's ProFound Breast Health Suite for 2D Mammography for Use as Independent Reader

GlobeNewswire August 14, 2023

iCAD to Report Second Quarter 2023 Financial Results on August 14, 2023

GlobeNewswire July 31, 2023

iCAD Signs Strategic Commercial Agreement with Radiology Partners, the Nation's Largest Radiology Practice

GlobeNewswire July 18, 2023